Bundled Care to Reduce Sepsis Mortality: The Improving Pediatric Sepsis Outcomes (IPSO) Collaborative.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 08 2023
Historique:
accepted: 12 04 2023
medline: 23 10 2023
pubmed: 12 7 2023
entrez: 12 7 2023
Statut: ppublish

Résumé

We sought to improve utilization of a sepsis care bundle and decrease 3- and 30- day sepsis-attributable mortality, as well as determine which care elements of a sepsis bundle are associated with improved outcomes. Children's Hospital Association formed a QI collaborative to Improve Pediatric Sepsis Outcomes (IPSO) (January 2017-March 2020 analyzed here). IPSO Suspected Sepsis (ISS) patients were those without organ dysfunction where the provider "intended to treat" sepsis. IPSO Critical Sepsis (ICS) patients approximated those with septic shock. Process (bundle adherence), outcome (mortality), and balancing measures were quantified over time using statistical process control. An original bundle (recognition method, fluid bolus < 20 min, antibiotics < 60 min) was retrospectively compared with varying bundle time-points, including a modified evidence-based care bundle, (recognition method, fluid bolus < 60 min, antibiotics < 180 min). We compared outcomes using Pearson χ-square and Kruskal Wallis tests and adjusted analysis. Reported are 24 518 ISS and 12 821 ICS cases from 40 children's hospitals (January 2017-March 2020). Modified bundle compliance demonstrated special cause variation (40.1% to 45.8% in ISS; 52.3% to 57.4% in ICS). The ISS cohort's 30-day, sepsis-attributable mortality dropped from 1.4% to 0.9%, a 35.7% relative reduction over time (P < .001). In the ICS cohort, compliance with the original bundle was not associated with a decrease in 30-day sepsis-attributable mortality, whereas compliance with the modified bundle decreased mortality from 4.75% to 2.4% (P < .01). Timely treatment of pediatric sepsis is associated with reduced mortality. A time-liberalized care bundle was associated with greater mortality reductions.

Identifiants

pubmed: 37435672
pii: 192529
doi: 10.1542/peds.2022-059938
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 by the American Academy of Pediatrics.

Auteurs

Raina Paul (R)

Division of Emergency Medicine, Children's Hospital of Orange County, University of California Irvine, Orange California.

Matthew Niedner (M)

Unaffiliated.

Ruth Riggs (R)

Children's Hospital Association, Lenexa, Kansas.

Troy Richardson (T)

Children's Hospital Association, Lenexa, Kansas.

Heidi Gruhler DeSouza (HG)

Children's Hospital Association, Lenexa, Kansas.

Jeffery J Auletta (JJ)

Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio.

Frances Balamuth (F)

Department of Pediatrics, University of Pennsylvania, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Deborah Campbell (D)

Kentucky Hospital Association, Louisville, Kentucky.

Holly Depinet (H)

Departments of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Leslie Hueschen (L)

University of Missouri-Kansas City, Children's Mercy Hospital, Kansas City, Missouri.

W Charles Huskins (WC)

Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, Minnesota.

Sarah B Kandil (SB)

Department of Pediatrics, Yale University School of Medicine, Yale New Haven Children's Hospital, New Haven, Connecticut.

Gitte Larsen (G)

Primary Children's Hospital, University of Utah, Salt Lake City, Utah.

Elizabeth H Mack (EH)

Medical University of South Carolina Children's Health, Charleston, South Carolina.

Gregory P Priebe (GP)

Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Department of Anesthesia, Harvard Medical School, Boston, Massachusetts.

Lori E Rutman (LE)

University of Washington, Seattle Children's Hospital, Seattle, Washington.

Melissa Schafer (M)

State University of New York Upstate Medical Center, Syracuse, New York.

Halden Scott (H)

Department of Pediatrics, University of Colorado School of Medicine, Children's Hospital Colorado, Denver, Colorado.

Pete Silver (P)

Cohen Children's Medical Center of New York, Queens, New York.

Erika L Stalets (EL)

Departments of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Beth A Wathen (BA)

Children's Hospital Colorado, Denver, Colorado.

Charles G Macias (CG)

Division of Pediatric Emergency Medicine, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, Ohio.

Richard J Brilli (RJ)

Nationwide Children's Hospital, Division of Pediatric Critical Care Medicine, Department of Pediatrics, Columbus, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH